MITOXANTRONE, 5-FU, AND LEUCOVORIN IN BREAST-CANCER

被引：2
|
作者：
SWAIN, SM
HONIG, SF
机构：
[1] Lombardi Cancer Research Center, Department of Medicine, Division of Medical Oncology, Washington, District of Columbia
来源：
MEDICAL AND PEDIATRIC ONCOLOGY | 1994年 / 22卷 / 06期
关键词：
MITOXANTRONE; 5-FLUOROURACIL; LEUCOVORIN; CHEMOTHERAPY OF BREAST CANCER;
D O I：
10.1002/mpo.2950220603
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Eighteen patients (17 evaluable for response) with metastatic breast cancer were treated with mitoxantrone 10 mg/m(2) day 1, followed by 5-fluorouracil 375 mg/m(2) day 1-5, and high-dose leucovorin 500 mg/m(2) day 1-5 given every 28 days. There was one complete and four partial responses for an objective response rate of 30% and 41% stable disease. The major toxicities were hematologic and gastrointestinal. This regimen has activity in metastatic breast cancer comparable to conventional and/or standard chemotherapy regimens for advanced disease. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码：370 / 374
页数：5
相关论文
共 50 条
  • [1] UFT/leucovorin vs 5-FU/leucovorin in colon cancer
    Smith, RE
    Lembersky, BC
    Wieand, HS
    Colangelo, L
    Mamounas, EP
    ONCOLOGY-NEW YORK, 2000, 14 (10): : 24 - 27
  • [2] Efficacy of adjuvant chemotherapy with 5-FU/leucovorin and 5-FU/levamisole colon cancer
    Porschen, R
    Bermann, A
    Löffler, T
    Haack, G
    Rettig, K
    Anger, Y
    Strohmeyer, G
    GASTROENTEROLOGY, 1998, 114 (04) : A664 - A664
  • [3] SEQUENTIAL METHOTREXATE AND 5-FU IN CMFP (CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FU, AND PREDNISONE) THERAPY FOR BREAST-CANCER
    CADMAN, EC
    GLICK, JH
    CROSS, J
    HORTON, J
    TAYLOR, SG
    CANCER TREATMENT REPORTS, 1984, 68 (06): : 877 - 879
  • [4] A COMPARATIVE-STUDY OF PALA, PALA PLUS 5-FU, AND 5-FU IN ADVANCED BREAST-CANCER
    MANN, GB
    HORTOBAGYI, GN
    BUZDAR, AU
    YAP, HY
    VALDIVIESO, M
    CANCER, 1985, 56 (06) : 1320 - 1324
  • [5] METHOTREXATE, MITOXANTRONE, 5-FLUOROURACIL AND LEUCOVORIN IN METASTATIC BREAST-CANCER PATIENTS
    MERLINI, L
    SECONDO, V
    MAMMOLITI, S
    BELLOTTI, P
    CASTELLO, C
    GALLO, L
    ANTICANCER RESEARCH, 1994, 14 (3B) : 1423 - 1425
  • [6] Gemcitabine/5-FU/leucovorin for the treatment of pancreatic cancer
    Malayeri, R.
    Boland, M. Ghassem
    Maadi, A. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] METASTATIC BREAST-CANCER - CHEMOTHERAPY WITH ADRIAMYCIN, VINDESINE, CYCLOPHOSPHAMIDE AND 5-FU - INTEREST OF CONTINUOUS 5-FU INFUSION
    JOUVE, M
    PALANGIE, T
    BELLI, L
    DORVAL, T
    GARCIAGIRALT, E
    BEUZEBOC, P
    SCHOLL, S
    MOSSERI, V
    LIVARTOWSKI, A
    VEDRENNE, J
    POUILLART, P
    BULLETIN DU CANCER, 1989, 76 (06) : 643 - 652
  • [8] CARBOPLATIN (CBDCA), 5-FLUOROURACIL (5-FU) AND MITOXANTRONE (DHAD) - AN EFFECTIVE AND WELL TOLERATED REGIMEN FOR METASTATIC BREAST-CANCER
    HIDALGO, OF
    GONZALEZ, FG
    VIEITEZ, JM
    REBOLLO, J
    TANGCO, E
    HERRANZ, P
    ANNALS OF ONCOLOGY, 1992, 3 (07) : 545 - 547
  • [9] THE IMPORTANCE OF DOSE SCHEDULING WITH MITOXANTRONE, 5-FLUOROURACIL AND LEUCOVORIN IN METASTATIC BREAST-CANCER
    JOLIVET, J
    BELANGER, K
    YELLE, L
    GUEVIN, R
    POTVIN, M
    WILSON, J
    RUDINSKAS, L
    LATREILLE, J
    DIONNE, J
    GAGNE, L
    AYOUB, J
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (05) : 626 - 628
  • [10] 5-Fluorouracil (5-FU) plus leucovorin versus 5-FU leucovorin plus interferon-A given as adjuvant chemotherapy in colon cancer
    Papacostas, P
    Stathopoulos, GP
    Malamos, NA
    Michailakis, E
    Rigatos, S
    Golematis, B
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 752 - 752
12345